This leads to the depletion of ATP in VHL-deficient ccRCC cells, while sparing normal renal epithelial cells, thus exploiting the metabolic differences between cancerous and normal cells [136]. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.